Association of Carotid Plaque and Serum Lipoprotein-Associated Phospholipase A2 (LP-PLA2) with Postoperative Delirium in Geriatric Patients Undergoing Hip Replacement: A Prospective Cohort Study

被引:2
|
作者
Wan, Tiantian [1 ]
Wei, Penghui [2 ]
Yao, Yong [3 ]
Liu, Hui [4 ]
Li, Jianjun [2 ]
机构
[1] Shandong First Med Univ, Dept Anesthesiol & Perioperat Med, Affiliated Hosp 1, Jinan, Shandong, Peoples R China
[2] Shandong Univ Qingdao, Dept Anesthesiol, Qilu Hosp, Qingdao, Shandong, Peoples R China
[3] Shandong Univ, Dept Crit Care Med, Qilu Hosp, Jinan, Shandong, Peoples R China
[4] Zhejiang Univ, Dept Anesthesiol, Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China
来源
MEDICAL SCIENCE MONITOR | 2020年 / 26卷
关键词
1-Alkyl-2-acetylglycerophosphocholine Esterase; Carotid Stenosis; Delirium; Geriatrics; ATHEROSCLEROSIS; LYSOPHOSPHATIDYLCHOLINE; EXPRESSION; A(2);
D O I
10.12659/MSM.927763
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The aim of this study was to investigate the relationships among carotid plaque (CP), serum lipoprotein-associated phospholipase (LP-PLA2), and POD in elderly patients. Material/Methods: Sixty-two elderly patients undergoing hip replacement with spinal-epidural anesthesia were divided into CP and non-CP groups based on the preoperative presence or absence of carotid atherosclerotic plaques, as assessed by ultrasound. POD was diagnosed by means of the Confusion Assessment Method (CAM). Blood samples were collected (preoperatively, postoperatively, and postoperative day 2) for the assessment of serum LP-PLA2 by enzyme-linked immunosorbent assay. The CP group was further divided into POD and no-POD subgroups based on the occurrence of POD. Results: The incidence of POD was higher in the CP group than in the non-CP group (P<0.05). While the LP-PLA2 level did not significantly differ between CP and non-CP groups preoperatively (P>0.05), it was higher in the CP group than in the non-CP group postoperatively and on postoperative day 2 (P<0.05). In the CP group, the LP-PLA2 level did not significantly differ between the subgroups preoperatively or postoperatively (P>0.05), but was significantly higher in the POD subgroup than in the no-POD subgroup on postoperative day 2 (P(0.05). Furthermore, the LP-PLA2 level on postoperative day 2 was an independent risk factor for POD (odds ratio: 1.03, 95% confidence interval: 1.00-1.07). Conclusions: The preoperative presence of carotid plaque is closely associated with a higher incidence of POD. The potential mechanism may involve the increased expression of LP-PLA2 in the serum, which can lead to plaque destabilization and subsequent inflammatory cascades.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Heritability of Plasma Lipoprotein-associated Phospholipase A2 (Lp-PLA2), a new marker of cardiovascular risk
    Lenzini, L.
    Caroccia, B.
    Wolfert, R.
    Szczech, R.
    Cesari, M.
    Narkiewicz, K.
    Williams, C. J.
    Rossi, G. P.
    HYPERTENSION, 2008, 52 (04) : 764 - 764
  • [22] Lipoprotein-associated phospholipase A2 (Lp-PLA2): a review of its role and significance as a cardiovascular biomarker
    Vittos, Oana
    Toana, Bogdan
    Vittos, Alexandros
    Moldoveanu, Elena
    BIOMARKERS, 2012, 17 (04) : 289 - 302
  • [23] Characterising the role of lipoprotein-associated phospholipase A2 (Lp-PLA2) in experimental autoimmune uveoretinitis (EAU)
    Beers, G.
    Boldison, J.
    Copland, D.
    Adamson, P.
    Nicholson, L.
    Dick, A.
    IMMUNOLOGY, 2013, 140 : 51 - 51
  • [24] The effect of percutaneous coronary intervention on transcoronary lipoprotein-associated phospholipase A2 (LP-PLA2) concentration
    Munir, M. S.
    Ahmed, A. H.
    Brewer, M. A.
    Shankar, K. J.
    Williams, S.
    Casscells, S. W.
    Wilson, J. M.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2006, 40 (06) : 898 - 899
  • [25] Functional impairment of two novel mutations detected in lipoprotein-associated phospholipase A2 (Lp-PLA2) deficiency patients
    Mitsuaki Ishihara
    Tadao Iwasaki
    Makoto Nagano
    Jun Ishii
    Mayumi Takano
    Takeshi Kujiraoka
    Masahiro Tsuji
    Hiroaki Hattori
    Mitsuru Emi
    Journal of Human Genetics, 2004, 49 : 302 - 307
  • [26] Functional impairment of two novel mutations detected in lipoprotein-associated phospholipase A2 (Lp-PLA2) deficiency patients
    Ishihara, M
    Iwasaki, T
    Nagano, M
    Ishii, J
    Takano, M
    Kujiraoka, T
    Tsuji, M
    Hattori, H
    Emi, M
    JOURNAL OF HUMAN GENETICS, 2004, 49 (06) : 302 - 307
  • [27] Smoking induces lipoprotein-associated Phospholipase A2 (Lp-PLA2) in cardiovascular disease free adults: the ATTICA study
    Panagiotakos, D.
    Tselepis, A.
    Pitsavos, C.
    Tellis, C.
    Chrysohoou, C.
    Skoumas, J.
    Stefanadis, C.
    EUROPEAN HEART JOURNAL, 2009, 30 : 363 - 363
  • [28] Stability of lipoprotein-associated phospholipase A2 (Lp-PLA2) levels in normal individuals: Biological variation study.
    Kim, NW
    Lee, SE
    Lanka, A
    Pangilinan, PF
    Wolfert, RL
    CLINICAL CHEMISTRY, 2002, 48 (06) : A98 - A98
  • [29] Correlation of lipoprotein-associated phospholipase a2 serum and tissue activity (Lp-PLA2) with carotid tissue macrophages and chlamydophila pneumoniae infection among patients at risk for stroke
    Atik, Berna
    Johnston, S. Claiborne
    Dean, Deborah
    STROKE, 2008, 39 (02) : 716 - 716
  • [30] Lipoprotein-associated phospholipase A2 (Lp-Pla2) gene is highly expressed in the aortic aneurysm samples and carotid plaques and is associated with expression of metalloproteinase
    Madjid, M.
    Haidari, M.
    Ali, M.
    Vela, D.
    Porat, E. E.
    Estrera, A. L.
    Safi, H. J.
    Casscells, W.
    EUROPEAN HEART JOURNAL, 2006, 27 : 974 - 974